Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate to Prevent Vertical Transmission of Hepatitis B in Mothers With High Viral Load

NCT04211805 is registered in ClinicalTrials.gov with New Discovery LLC as lead sponsor.

NCT NCT04211805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate to Prevent Vertical Transmission of Hepatitis B in Mothers With High Viral Load
Lead sponsor
New Discovery LLC
Phase
Observational
Overall status
Unknown status
Start date
January 27, 2020
Completion date
September 30, 2021
Enrollment
450 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, pregnancy related